<DOC>
	<DOCNO>NCT02536118</DOCNO>
	<brief_summary>Medtronic sponsor Micra Registry confirm safety effectiveness Micra Transcatheter Pacing System ( Micra system ) use intend , `` real-world '' clinical practice , follow commercial release . The Micra Registry conduct within Medtronic 's Product Surveillance Registry .</brief_summary>
	<brief_title>Micra Transcatheter Pacing System Post-Approval Registry</brief_title>
	<detailed_description>The Micra Registry global , prospective , observational , multi-site registry . All patient enrol Micra Registry prospectively follow minimum 9 year post implant registry closure . Enrolled patient schedule follow-up visit least annually prompt reportable adverse event ; however , Micra system follow-up patient visit report . Therefore , frequent schedule visit occur per provider 's standard care practice , visit report . The total estimated registry duration 11 year .</detailed_description>
	<mesh_term>Bradycardia</mesh_term>
	<criteria>Patient legally authorize representative provide write authorization and/or consent per institution geographical requirement Patient intend receive treat Micra Transcatheter Pacing System must enrol prior TPS implant procedure Patient , expect inaccessible followup Patient exclusion criterion require local law Patient currently enrol plan enroll concurrent drug and/or device study may confound result</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>